Skip to content
Menu
Our Science
Therapeutic Approach
Bryostatin Platform
Partnering
Our Team
Publications
News
Contact Us
Publication Category:
Effects on Tumor Antigens
Bryostatin enhances efficacy of an antibody drug conjugate against CD22 in vitro
Bryostatin enhances expression of CD20 in cancer cell line
Bryostatin induces CD22 expression in early clinical study
CD22 CAR-T rescues CD19 CAR-T relapses
Bryostatin enhances CD22 CAR-T efficacy in mice
Modulation of Target Antigen Density Improves CAR T-cell Functionality and Persistence